News
The ALS market is witnessing robust growth driven by increased disease awareness, advancements in genetic research, and an expanding pipeline of ther ...
14h
News Medical on MSNNew UAB-developed gene therapy for ALS receives orphan drug designationThe U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...
The global amyotrophic lateral sclerosis treatment market is undergoing gradual yet impactful transformation, driven by advancements in neurodegenerative disease research, gene-targeted therapies ...
At more than 70 locations from around the state of Nebraska, the 2025 Cornhusker State Games kicked-off on July 10. For the ...
Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...
At more than 70 locations from around the state of Nebraska, the 2025 Cornhusker State Games kicked-off on July 10. For the first time, the shooting sports events of the Cornhusker State Games are ...
Motor neurone disease (MND) is a rare but progressive neurological disorder characterised by the degeneration of motor ...
Greek actor Gerasimos Michelis passed away on July 15 at the age of 60. The actor's family reportedly announced the news on Facebook through the statement: "This morning, our beloved Gerasimos left ...
Exposure to toxic cyanobacterial blooms may accelerate fatal outcomes in amyotrophic lateral sclerosis linked to environmental factors.
KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and oxidative stress.
DelveInsight’s, “Amyotrophic Lateral Sclerosis (ALS) – Pipeline Insight, 2025,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results